Heterocyclic Building Blocks

Sulfur-Containing Heterocycles

Thienopyridine Derivatives Thiophene Derivatives

Indole Derivatives

Spiro cyclic Heterocycles

Bridged Bicyclic Heterocycles

Pidine Derivatives

Pyridine Derivatives

Isoquinoline Derivatives

Fused Bicyclic Heterocycles

Pyridine Derivatives

Pyrazole Derivatives

Sulfur-Containing Heterocycles

Thiophene Derivatives

Fused Bicyclic Heterocycles

Azepine Derivatives

Benzazepines

Pyridazine Derivatives

Fused Bicyclic Heterocycles

Pyrazolo-pyrimidine Derivatives Isoquinoline Derivatives Pyrrolopyrimidine Derivatives Pyrrolopyridine Derivatives Imidazopyridine Derivatives Pyrazolo-pyridine Derivatives

Sulfur-Containing Heterocycles

Spiro cyclic Heterocycles

Coumarin Derivatives

Pyrrole Derivatives

Benzoxaborole Derivatives

Pyridone Derivatives

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Kinase Inhibitors

En Inhibitor Intermediates

Kinase Inhibitors

Alkylating Agents

Cytotoxic Natural Products

Neurological Intermediates

Anticonvulsants

Cardiovascular Intermediates

Cardiac Glycosides

Vasodilator Intermediates

Angiotensin II Receptor Blockers

Calcium Channel Blockers

Organic Synthesis Intermediates

Nitrile Intermediates

Heterocyclic Building Blocks

Quinoline Derivatives

Aromatic Alcohols

Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Halogenated Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Nitro Aromatic Alcohols Halogenated Aromatic Alcohols

Ketone Intermediates

Antidiabetic Intermediates

Antimalarial Intermediates

Amide Intermediates

Benzamide Derivatives

Enzyme Inhibitor Intermediates

Kinase Inhibitors

Carbonic Anhydrase Inhibitors

Nitro Aromatic Derivatives

Drug Discovery Reagents

Antimalarial Intermediates

Oncology Drug Intermediates

Enzyme Inhibitor Intermediates

Sulfonamide Intermediates

Neurological Research Reagents

Heterocyclic Building Blocks

Antihistamine Intermediates

Phenolic Intermediates

Halogenated Phenols

Aliphatic Carboxylic Acid Derivatives

Malonic Acid Derivatives

Drug Delivery Intermediates

Surface Modification Reagents

REAGENT

(R)-Piperidine-3-Carboxylic Acid Ethyl Ester Hydrochloride

≥98%

CAS:37675-19-7

Formula:C₈H₁₆ClNO₂

MW:193.67 g/mol

฿790.00

ข้อมูล

REAGENT

(4aR,7aS)-rel-tert-Butyl tetrahydro-2H-[1,4]dioxino[2,3-c]pyrrole-6(3H)-carboxylate

99%

CAS:694439-03-7

Formula:C₁₁H₁₉NO₄

MW:229.27 g/mol

฿143.00

ข้อมูล

REAGENT

(1R,2S,5S)-Methyl 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride

97%

CAS:565456-77-1

Formula:C₉H₁₆ClNO₂

MW:205.69 g/mol

฿730.00

ข้อมูล

REAGENT

methyl (3R)-3-acetamido-4-(2,4,5-trifluorophenyl)butanoate

97%

CAS:1234321-83-5

Formula:C₁₃H₁₄F₃NO₃

MW:289.25 g/mol

฿11,650.00

ข้อมูล

REAGENT

R-(-)-3-ethyl-morpholine

98%

CAS:74572-05-7

Formula:C₆H₁₃NO

MW:115.17 g/mol

฿25,180.00

ข้อมูล

REAGENT

(3R,4R,5S)-Ethyl 4-(N-(tert-butyl)acetamido)-5-(diallylamino)- 3-(pentan-3-yloxy)cyclohex-1-enecarboxylate hydrochloride

98%

CAS:651324-08-2

Formula:C₂₆H₄₅ClN₂O₄

MW:485.1 g/mol

฿12,800.00

ข้อมูล

REAGENT

(R,S)-4-BOC-3-CARBOXYMETHYL-PIPERAZIN-2-ONE

95%

CAS:863307-54-4

Formula:C₁₁H₁₈N₂O₅

MW:258.271 g/mol

฿21,540.00

ข้อมูล

REAGENT

(R)-()-2-Bromopropionic Acid

>98.0%(GC)

CAS:10009-70-8

Formula:C₃H₅BrO₂

MW:152.98 g/mol

฿1,510.00

ข้อมูล

REAGENT

(2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one

95%

CAS:287930-75-0

Formula:C₂₁H₁₉F₆NO₃

MW:447.37 g/mol

฿2,480.00

ข้อมูล

REAGENT

(5R,6S)-Allyl 6-((R)-1-((tert-butyldimethylsilyl)oxy)ethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

98%

CAS:120705-67-1

Formula:C₂₁H₃₃NO₅SSi

MW:439.64 g/mol

฿660.00

ข้อมูล

ตะกร้า

ไม่มีสินค้า

Subtotal: 0.00

รวมทั้งสิ้น 0.00 THB

ตะกร้า สั่งซื้อ

Researcher Network คุณอยู่ในองค์กรการวิจัยใดๆ หรือไม่? ใช้อีเมลองค์กรของคุณเพื่อตรวจสอบสิทธิ์และข้อกำหนดใบกำกับภาษีขององค์กร ดูรายละเอียด